Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Epilepsy Drugs Market Landscape

4.1 Overview

5. Asia Pacific Epilepsy Drugs Market - Key Industry Dynamics

5.1 Market Drivers

5.1.1 Growing Prevalence of Epilepsy

5.1.2 Increasing Number of Elderly People

5.2 Market Restraints

5.2.1 Recall of Therapeutic Products

5.3 Market Opportunities

5.3.1 Several Epilepsy Drugs Nearing Patent Expiration

5.4 Future Trends

5.4.1 Increasing Product Approvals

5.5 Impact Analysis

6. Epilepsy Drugs Market - Asia Pacific Market Analysis

6.1 Overview

6.2 Asia Pacific Epilepsy Drugs Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 - by Treatment

7.1 Overview

7.2 Asia Pacific Epilepsy Drugs Market Revenue Share, by Treatment 2022 & 2030 (%)

7.3 First Generation Antiepileptics

7.3.1 Overview

7.3.2 First Generation Antiepileptics: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Second Generation Anti-epileptics

7.4.1 Overview

7.4.2 Second Generation Anti-epileptics: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Third Generation Anti-epileptics

7.5.1 Overview

7.5.2 Third Generation Anti-epileptics: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview

8.2 Asia Pacific Epilepsy Drugs Market Revenue Share, by Distribution Channel 2022 & 2030 (%)

8.3 Hospital Pharmacy

8.3.1 Overview

8.3.2 Hospital Pharmacy: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Retail Pharmacy Stores

8.4.1 Overview

8.4.2 Retail Pharmacy Stores: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Asia Pacific Epilepsy Drugs Market, by Key Country- Revenue (2022) (US$ Million)

9.1.1 Asia Pacific Epilepsy Drugs Market, by Country, 2022 & 2030 (%)

9.1.1.1 China: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.1.1 Overview

9.1.1.1.2 China: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.1.3 China: Asia Pacific Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.1.4 China: Asia Pacific Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.1.2 Japan: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.2.1 Overview

9.1.1.2.2 Japan: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.2.3 Japan: Asia Pacific Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.2.4 Japan: Asia Pacific Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.1.3 India: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.3.1 Overview

9.1.1.3.2 India: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.3.3 India: Asia Pacific Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.3.4 India: Asia Pacific Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.1.4 Australia: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.4.1 Overview

9.1.1.4.2 Australia: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.4.3 Australia: Asia Pacific Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.4.4 Australia: Asia Pacific Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.1.5 South Korea: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.5.1 Overview

9.1.1.5.2 South Korea: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.5.3 South Korea: Asia Pacific Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.5.4 South Korea: Asia Pacific Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.1.6 Rest of Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.6.1 Overview

9.1.1.6.2 Rest of Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

9.1.1.6.3 Rest of Asia Pacific Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)

9.1.1.6.4 Rest of Asia Pacific Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Epilepsy Drugs Market-Industry Landscape

10.1 Overview

10.2 Growth Strategies in the Epilepsy Drugs Market

10.3 Inorganic Growth Strategies

10.3.1 Overview

10.4 Organic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Novartis AG

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Pfizer Inc

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 GSK Plc

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Abbott Laboratories

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Sanofi SA

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Teva Pharmaceutical Industries Ltd

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Alkem Laboratories Ltd

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Asia Pacific Epilepsy Drugs Market Segmentation

Table 2. China: Asia Pacific Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 3. China: Asia Pacific Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 4. Japan: Asia Pacific Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 5. Japan: Asia Pacific Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 6. India: Asia Pacific Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 7. India: Asia Pacific Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 8. Australia: Asia Pacific Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 9. Australia: Asia Pacific Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 10. South Korea: Asia Pacific Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 11. South Korea: Asia Pacific Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 12. Rest of Asia Pacific Epilepsy Drugs Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 13. Rest of Asia Pacific Epilepsy Drugs Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 14. Recent Inorganic Growth Strategies in the Epilepsy Drugs Market

Table 15. Recent Organic Growth Strategies in the Asia Pacific Epilepsy Drugs Market

Table 16. Glossary of Terms, Asia Pacific Epilepsy Drugs Market

List of Figures

Figure 1. Asia Pacific Epilepsy Drugs Market Segmentation, By Country

Figure 2. Asia Pacific Epilepsy Drugs Market: Key Industry Dynamics

Figure 3. Asia Pacific Epilepsy Drugs Market: Impact Analysis of Drivers and Restraints

Figure 4. Asia Pacific Epilepsy Drugs Market Revenue (US$ Mn), 2022 - 2030

Figure 5. Asia Pacific Epilepsy Drugs Market Revenue Share, by Treatment 2022 & 2030 (%)

Figure 6. First Generation Anti-epileptics: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Second Generation Anti-epileptics: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Third Generation Anti-epileptics: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Asia Pacific Epilepsy Drugs Market Revenue Share, by Distribution Channel 2022 & 2030 (%)

Figure 10. Hospital Pharmacy: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Retail Pharmacy Stores: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Others: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Asia Pacific Epilepsy Drugs Market, by Key Country - Revenue (2022) (US$ Million)

Figure 14. Asia Pacific Epilepsy Drugs Market, by Country, 2022 & 2030 (%)

Figure 15. China: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Japan: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. India: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Australia: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. South Korea: Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Rest of Asia Pacific Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Growth Strategies in the Epilepsy Drugs Market